Generics - Mylan Laboratories, Asia-Pacific

Filter

Popular Filters

Mylan debuts Hertraz, first Herceptin biosimilar, in India

Mylan debuts Hertraz, first Herceptin biosimilar, in India

03-02-2014

US generics major Mylan has launched the world's first trastuzumab biosimilar in India. The product,…

Asia-PacificBioconBiosimilarsGenericsHerceptinHertrazIndiaMarkets & MarketingMylan LaboratoriesOncologyRoche

Mylan-Biocon Herceptin biosimilar gets first Indian approval

Mylan-Biocon Herceptin biosimilar gets first Indian approval

26-11-2013

US generic major Mylan says that its partner, India-based biotechnology firm Biocon has received approval…

Asia-PacificBioconBiosimilarsGenericsHerceptinHertrazMylan LaboratoriesOncologyRegulationRoche

Mylan's deal to acquire Strides Arcolab's unit looks set to proceed

22-08-2013

US generics and specialty drugmaker Mylan (NYSE: MYL) $1.6-billion foreign direct investment proposal…

Agila SpecialitesAsia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesRegulationStrides Arcolab

Mylan delivers "one pill once a day" ARV in South Africa; Cipla Debuts first Enbrel biosimilar

17-04-2013

USA-based generic drugmaker Mylan (Nasdaq: MYL) says that it has delivered, through its South African-based…

AmgenAnti-Arthritics/RheumaticsAnti-viralsAsia-PacificBiotechnologyCiplaEnbrelEtaceptGenericsMarkets & MarketingMylan LaboratoriesPfizerRest of the World

Mylan buys Indian production unit from SMS Pharma for $33 million

18-10-2012

Following speculation that started last month, India's SMS Pharmaceuticals this week confirmed that it…

Asia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesProductionSMS Pharmaceuticals

Mylan chosen to supply ARVs to India's national AIDS control body

04-09-2012

Leading USA-based generic drugmaker Mylan (Nasdaq: MYL) says that its India-based subsidiary Mylan Laboratories…

Anti-viralsAsia-PacificGenericsMarkets & MarketingMylan Laboratories

Pfizer teams up with Mylan to drive generics business in Japan

23-08-2012

Global pharma behemoth Pfizer (NYSE: OFE) and generics drug major Mylan (Nasdaq: MYL) have signed a definitive…

Asia-PacificGenericsMarkets & MarketingMylan LaboratoriesPfizerProduction

Mylan starts operating in India, with portfolio of ARVs

07-08-2012

US generics and specialty drugmaker Mylan (Nasdaq: MYL) says that its India based subsidiary, Mylan Pharmaceuticals…

Anti-viralsAsia-PacificGenericsMarkets & MarketingMylan Laboratories

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top